CAS No. 67-47-0
EC No. 200-654-9
Synonyms 2-Furaldehyde, 5-(hydroxymethyl)-; 2-Furancarboxaldehyde-5-(hydroxymethyl)-; 2-Hydroxymethyl-5-furfural; 5-(Hydroxymethyl)furfural; 5-Hydroxymethyl-2-formylfuran; 5-(Hydroxymethyl)-2-furaldehyde; 5-(Hydroxymethyl)-2-furancarbonal; 5-(Hydroxymethyl)-2-furancarboxaldehyde; 5-(Hydroxymethyl)-2-furfural; 5-Hydroxymethylfuraldehyde; 5-(hydroxymethyl)furan-2-carbaldehyde; 5-Oxymethylfurfurole; Hydroxymethylfurfural; Hydroxymethylfurfuralaldehyde 


5-HMF | 5-Hydroxymethylfurfural | CAS 67-47-0 is derived from sugars and the link between biomass and furan-based chemicals. With its functional groups and reaction sites, 5-HMF is a versatile, renewable building block.

Intermediates – 5-HMF can be converted into interesting downstream products:

  • 2,5-Furandicarboxylic acid, which has been proposed as a replacement for Terephthalic acid in the production of polyesters
  • 2,5-Dimethylfuran a liquid that is a potential biofuel with greater energy content than bioethanol
  • 2,5-bis(hydroxymethyl)furan
  • gamma-Hydroxyvaleric acid and gamma-Valerolactone by catalyzed hydrolysis
  • 2,5-Furandimethanol
  • 5-Methyl furfural
  • 2,5-Hexanedione
  • (5-Methylfuran-2-yl)methanol
  • Dimethyl furan-2,5-dicarboxylate

​Industrial uses

  • Bio-based 5-HMF is considered to be an interesting substitute for Formaldehyde in PF resins.

Food, Feed & Beverages

  • 5-HMF is a promising substance for a range of innovative functional food and feed applications.

    Pharma & Healthcare
  • As an active pharmaceutical ingredient (API) the bio-based molecule has the potential for novel applications in the pharmaceutical industry.

  • 5-Hydroxymethyl-2-furancarboxylic acid can be used as a building block in the enzymatic synthesis of macrocyclic oligoesters.

  • 5-HMF is an intermediate in the titration of hexoses in the Molisch's test.

  • A major metabolite in humans is 5-hydroxymethyl-2-furoic acid (HMFA), which is excreted in urine.

    5-HMF binds intracellular sickle hemoglobin (HbS). Preliminary in vivo studies using transgenic sickle mice showed that orally administered 5-HMF inhibits the formation of sickled cells in the blood. Under the development code Aes-103, HMF has been considered for the treatment of sickle cell disease.

    Packaging & Shelf Life

    Packaging upon your request

    1-year shelf life at ambient temperature

    Health & Safety

Detailed information on the product described can be found in our relevant Health and Safety Information (Material Safety Data Sheet).

This website uses cookies to enable certain features and to improve the offer. By continuing, you agree to the use of cookies.
More information